John and Rebecca Moores commit $20 million towards planned UCSD Cancer Center facility

May 03, 2000

University nearing $50 million in private fund raising to establish state-of-the-art cancer facility in San Diego

The University of California, San Diego (UCSD) today announced that it has secured $47 million in private support to build a Cancer Center facility dedicated to research, patient care and community service. The university's overall goal is to secure $75 million to construct the facility and $25 million to support new clinical care initiatives.

A $20 million philanthropic gift from John Moores, majority owner of San Diego Padres and Regent of the University of California, and his wife Rebecca, is among the largest gifts from private individuals ever received by UCSD and the largest given toward the Cancer Center initiative. Pending Regents approval, the university will recognize the gift by naming the center the John and Rebecca Moores UCSD Cancer Center. A $15 million gift from Jerome and Miriam Katzin, longtime supporters and volunteers at UCSD, also has been committed to the initiative.

UCSD Cancer Center is one of just 59 centers in the United States to hold a National Cancer Institute (NCI) designation. As such, it ranks among the top centers in the nation conducting basic and clinical research, and providing advanced patient care.

Founded in 1979, the UCSD Cancer Center has grown as a broad collaboration among physicians and basic and clinical researchers, all dedicated to improving methods of preventing, diagnosing and treating the nation's number two killer. The university plans to unite more than 300 physicians, scientists and professional staff in one state-of-the-art clinical and research facility. The John and Rebecca Moores UCSD Cancer Center facility is planned for a site near the UCSD Thornton Hospital in La Jolla, on the university's east campus.

"Consolidating our cancer-related activities in a central location has been a priority for UCSD and is an important development for cancer care in the region, as well as for the advancement of scientific research which may impact people worldwide. We are deeply grateful to John and Becky Moores and Jerome and Miriam Katzin, for their vision and commitment to UCSD, and to the people of San Diego," said Robert C. Dynes, UCSD chancellor. "While much more work is required to finalize plans for the facility and to seek Regents approval for the proposed center, we are thrilled to announce these gifts and to celebrate approaching the half-way mark in our philanthropic fund raising for the center."

John and Rebecca Moores have a longstanding commitment to supporting cancer-related activities and causes in San Diego. Furthermore, with the encouragement of the Moores, the San Diego Padres have actively supported the Cindy Matters Fund, which benefits pediatric cancer programs at UCSD. To date, the Padres have contributed more than $400,000 to the fund.

"When we lived in Houston we observed the profound impact of a vigorous, highly regarded cancer center equally dedicated to research and patient care," said John Moores. "We believe that the superb, comprehensive cancer program at UCSD is poised to join the ranks of the nation's premier cancer centers, improving access to the best available cancer care through leadership and partnership. We are excited to be a part of the university's vision for a world-class cancer program, which we believe will accelerate the pace of discovery and bring visibility and resources to our region as a recognized leader in the battle against cancer."

Jerome Katzin serves on the Cancer Center Foundation Board and has worked hard over the years to bring to reality a modern new facility for cancer research and clinical care.

"It has been exciting to watch the UCSD Cancer Center develop and grow as an NCI clinical center, " said Jerome Katzin. "This initiative will result in a closer and more effective integration of these services for the community."

UC President and former UCSD Chancellor Richard C. Atkinson, and his wife Rita, also have made a major gift to the Cancer Center initiative. During Atkinson's tenure at UCSD, he envisioned a world-class Cancer Center to anchor its academic medical campus.

"Watching UCSD's Cancer Center evolve has been particularly gratifying for me," Atkinson said. "Now, as it approaches the next phase of its development, I know that this facility, and the work of these researchers and practitioners, will have a profound impact on the San Diego community, and beyond."

Other donors who have given in excess of $1 million since December 1999 toward the UCSD Cancer Center building project include: William and Robin Comer, Maurice and Charmaine Kaplan, Ron and Mary Taylor, and Frank and Lee Goldberg.

"Only with the support of our donors are we are able to pursue our goals. We are extremely grateful to have this level of community participation," Dynes added.

The new facility is still on the drawing boards, but is currently envisioned as containing 270,000 gross sq. ft. of research space, outpatient clinical services, and space for community education and outreach programs. Cancer patients at UCSD will be able to receive all their outpatient care within one facility, helping ease the stress and strain for patients and their families.

"This initiative is not just about a new building," said David Tarin, M.D., Ph.D., director of the UCSD Cancer Center. "The generosity of our benefactors, and the hard work of everyone involved in this initiative, is focused on fulfilling the commitment we have to our community which is to provide the best cancer care available constantly improved by the highest quality of research. The new facility is designed to bring all of the components of the Cancer Center together to create a whole that is greater than the sum of its parts."

"We are entering an era when the rapid pace of scientific discovery is giving us powerful new tools to manage devastating diseases such as cancer. This initiative will further strengthen the many exciting research and clinical activities already in place at UCSD," said David Bailey, interim vice chancellor for health sciences and dean, school of medicine. "The greatest impact the new facility will have will be on the lives of cancer patients and their families, who will benefit directly from the translation of research breakthroughs into increased survival rates, improved quality of life and even cures."

The UCSD Cancer Center is currently participating in discussions to form a regional cancer consortium in San Diego which comprises some 20 research and clinical care organizations dedicated to cancer prevention, treatment and research. The consortium is being formed with funding provided by the tobacco industry settlement.

"The regional consortium is being designed to help us share ideas and resources, improving cancer treatment for patients throughout the region," said Bailey. "As consortium members become stronger, the group becomes stronger, and the community benefits as a result."

The proposed John and Rebecca Moores UCSD Cancer Center facility may be ready for occupancy as early as fall 2003, pending Regental approval and fund raising.
Media Contacts: Leslie Franz, 858-543-6201, Karen Gajewski, 858-822-3353,

University of California - San Diego

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to